We are live on ! Find out more
ACA

Apis Capital Advisors Portfolio holdings

AUM $648M
1-Year Est. Return 302.67%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+302.67%
3 Year Est. Return
+1,035.2%
5 Year Est. Return
+2,376.05%
10 Year Est. Return
–
AUM
$72.3M
AUM Growth
-$16.8M
Cap. Flow
-$6.93M
Cap. Flow %
-9.58%
Top 10 Hldgs %
65.66%
Holding
56
New
13
Increased
14
Reduced
12
Closed
13

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$4.63M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$3.09M
3
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$3M
4
BLUE
bluebird bio
BLUE
+$1.74M
5
CYH icon
Community Health Systems
CYH
+$1.28M

Top Sells

Rank Stock Value
1
SYNA icon
Synaptics
SYNA
+$4.6M
2
CRTO icon
Criteo S.A. Ordinary Shares
CRTO
+$4.38M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.4M
4
UFI icon
UNIFI
UFI
+$2.01M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 44.66%
2 Industrials 18.39%
3 Technology 16.76%
4 Communication Services 3.37%
5 Consumer Discretionary 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$11.3M 15.6%
286,600
+23,900
+9% +$869K
SIMO icon
2
Silicon Motion
SIMO
$8.6B
$6.76M 9.35%
247,370
-42,630
-15% -$1.14M
TARO
3
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$4.94M 6.84%
34,600
-6,250
-15% -$874K
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$4.15M 5.74%
296,601
-56,399
-16% -$885K
MDVN
5
DELISTED
MEDIVATION, INC.
MDVN
$3.97M 5.5%
+93,500
New +$4.63M
BSTC
6
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.73M 5.17%
85,770
+9,806
+13% +$529K
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$3.29M 4.55%
+35,750
New +$3.09M
ENTA icon
8
Enanta Pharmaceuticals
ENTA
$366M
$3.22M 4.45%
89,100
-43,500
-33% -$1.87M
ENSG icon
9
The Ensign Group
ENSG
$10.4B
$3.17M 4.39%
159,003
+9,920
+7% +$228K
GILD icon
10
Gilead Sciences
GILD
$162B
$2.95M 4.08%
30,000
+1,800
+6% +$200K
AAPL icon
11
Apple
AAPL
$4.54T
$2.76M 3.81%
100,000
-56,600
-36% -$1.66M
ANAC
12
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$2.71M 3.75%
+23,000
New +$3M
BLUE
13
DELISTED
bluebird bio
BLUE
$2.64M 3.65%
2,383
+955
+67% +$1.74M
CTRE icon
14
CareTrust REIT
CTRE
$9.91B
$1.64M 2.27%
144,300
+6,300
+5% +$76.3K
GMLP
15
DELISTED
Golar LNG Partners LP
GMLP
$1.63M 2.26%
111,220
+37,790
+51% +$773K
CRTO icon
16
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$1.56M 2.16%
41,590
-95,660
-70% -$4.38M
TRIP icon
17
TripAdvisor
TRIP
$1.65B
$1.53M 2.12%
24,340
-660
-3% -$49.9K
ELLI
18
DELISTED
Ellie Mae Inc
ELLI
$1.51M 2.09%
22,750
+4,430
+24% +$327K
AMN icon
19
AMN Healthcare
AMN
$1.3B
$996K 1.38%
+33,200
New +$1.1M
CYH icon
20
Community Health Systems
CYH
$393M
$988K 1.37%
+27,951
New +$1.28M
VG
21
DELISTED
Vonage Holdings Corporation
VG
$873K 1.21%
+148,400
New +$842K
MBLY
22
DELISTED
Mobileye N.V.
MBLY
$819K 1.13%
+18,000
New +$989K
MGPI icon
23
MGP Ingredients
MGPI
$379M
$480K 0.66%
+30,000
New +$470K
HMLP
24
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$385K 0.53%
81,000
+12,000
+17% +$223K
SPY icon
25
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$383K 0.53%
+2,000
New +$406K
1
2 3

Similar funds

TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM
RK
Rather & Kittrell Knoxville, Tennessee $648M AUM 14.68% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return
ITC
Inspire Trust Company Reno, Nevada $648M AUM 19.45% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
SCM
Stevens Capital Management Radnor, Pennsylvania $649M AUM 27.37% 1-Year Est. Return

Apis Capital Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Apis Capital Advisors held 56 positions worth $72.3M, down 19% from $89.1M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Apis Capital Advisors withdrew a net $6.93M in Q3 2015, closing 13 positions and reducing 12 holdings. Its most notable exit was Synaptics, an estimated $4.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Industrials and Technology.

Against the trend, Apis Capital Advisors opened a new position in MEDIVATION, INC. worth $3.97M.

  • Apis Capital Advisors's largest Q3 2015 buy was MEDIVATION, INC.: 93,500 shares worth $3.97M.
  • Apis Capital Advisors added most to bluebird bio in Q3 2015, an estimated $1.74M increase.
  • Apis Capital Advisors's biggest Q3 2015 reduction was Criteo S.A. Ordinary Shares, cutting an estimated $4.38M.
  • Apis Capital Advisors fully exited Synaptics in Q3 2015, selling an estimated $4.6M.
  • Apis Capital Advisors's ten largest holdings make up 66% of its $72.3M portfolio in Q3 2015.
  • Apis Capital Advisors opened 13 new positions and closed 13 in Q3 2015.
  • Apis Capital Advisors's portfolio value fell 19% quarter-over-quarter to $72.3M.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.